http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011529084-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4711 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B40-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate | 2009-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2011529084-A |
| titleOfInvention | Amyloid β peptide analogues, oligomers thereof, processes for preparing said analogues or oligomers and compositions comprising said analogues or oligomers and their use |
| abstract | The invention comprises (i) forming a loop, (ii) having at least 66% identity with the amino acid sequence of a natural Aβ peptide or a portion thereof, and (iii) having at least 6 consecutive amino acid residues. And (iv) for an amyloid β peptide analogue comprising an amino acid sequence having at least two non-contiguous amino acid residues covalently linked to each other or a peptidomimetic thereof, for an oligomer comprising said amyloid β peptide analogue, The invention relates to processes for preparing amyloid β peptide analogs or oligomers, to compositions comprising amyloid β peptide analogs or oligomers, and to treat or prevent amyloidosis (eg, by active immunization), to diagnose amyloidosis and amyloid Bind to β-peptide analogs or oligomers To the use of the amyloid β peptide analogue or oligomer, such as used for providing agents capable. The present invention relates to agents (eg, antibodies) that can bind to amyloid β peptide analogs or oligomers, compositions comprising the agents, and uses for treating or preventing amyloidosis (eg, by passive immunization) and for diagnosing amyloidosis It also describes the use of agents such as |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7357354-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021001203-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017532289-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016505391-A |
| priorityDate | 2008-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1048.